MiMedx Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	393.44	348.88	321.48	267.84	242.02	248.23
Revenue Growth (YoY)	14.77%	8.52%	20.03%	10.67%	-2.50%	-17.05%
Cost of Revenue	70.87	60.07	54.63	48.32	39.63	39.33
Gross Profit	322.58	288.81	266.84	219.53	202.39	208.9
Selling, General & Admin	254.21	216.39	216.3	220.85	198.64	240.49
Research & Development	13.91	12.34	12.67	12.7	9.93	11.72
Amortization of Goodwill & Intangibles	0.5	0.77	0.76	0.7	0.82	1.07
Operating Expenses	268.62	229.5	229.73	234.25	209.39	253.28
Operating Income	53.96	59.31	37.12	-14.73	-7	-44.37
Interest Expense	-1.9	-3.94	-6.58	-5.05	-4.98	-8.27
Interest & Investment Income	4.33	2.93	0.12	0.03	-	0.33
Other Non Operating Income (Expenses)	-0.58	-0.57	-0.03	-0	-0.02	-0
EBT Excluding Unusual Items	55.81	57.74	30.63	-19.75	-12	-52.32
Asset Writedown	-0.09	-0.45	-	-	-0.05	-1.03
Other Unusual Items	-	-	-	-	-	-8.2
Pretax Income	55.72	57.29	30.63	-19.75	-12.05	-61.54
Income Tax Expense	14.89	15.3	-36.81	0.21	0.25	-12.26
Earnings From Continuing Operations	40.83	42	67.44	-19.95	-12.3	-49.28
Earnings From Discontinued Operations	-	0.42	-9.21	-10.24	2.02	-
Net Income	40.83	42.42	58.23	-30.2	-10.29	-49.28
Preferred Dividends & Other Adjustments	-	-	11.64	6.58	6.14	34.04
Net Income to Common	40.83	42.42	46.59	-36.78	-16.42	-83.33
Net Income Growth	-53.85%	-27.15%	-	-	-	-
Shares Outstanding (Basic)	147	147	116	113	110	108
Shares Outstanding (Diluted)	150	149	146	113	110	108
Shares Change (YoY)	-12.06%	2.11%	29.27%	2.32%	1.94%	1.23%
EPS (Basic)	0.28	0.29	0.40	-0.33	-0.15	-0.77
EPS (Diluted)	0.27	0.28	0.36	-0.33	-0.15	-0.77
EPS Growth	-47.92%	-22.18%	-	-	-	-
Free Cash Flow	66.82	64.51	24.79	-19.41	-5.2	-34.49
Free Cash Flow Per Share	0.45	0.43	0.17	-0.17	-0.05	-0.32
Gross Margin	81.99%	82.78%	83.00%	81.96%	83.63%	84.16%
Operating Margin	13.71%	17.00%	11.54%	-5.50%	-2.89%	-17.88%
Profit Margin	10.38%	12.16%	14.49%	-13.73%	-6.78%	-33.57%
Free Cash Flow Margin	16.98%	18.49%	7.71%	-7.25%	-2.15%	-13.89%
EBITDA	68.61	65.35	40.54	-10.68	-1.82	-37.52
EBITDA Margin	17.44%	18.73%	12.61%	-3.99%	-0.75%	-15.11%
D&A For EBITDA	14.65	6.04	3.43	4.05	5.18	6.86
EBIT	53.96	59.31	37.12	-14.73	-7	-44.37
EBIT Margin	13.71%	17.00%	11.54%	-5.50%	-2.89%	-17.88%
Effective Tax Rate	26.73%	26.70%	-	-	-	-
Advertising Expenses	-	0.6	0.6	0.2	0.1	0.1

Updated Oct 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q